Open AccessThe European Pharmacopoeia: A Common European Initiative by the Council of Europe
Author(s) -
Caroline Larsen Le Tarnec
Publication year - 2004
Publication title -
chimia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.387
H-Index - 55
eISSN - 2673-2424
pISSN - 0009-4293
DOI - 10.2533/000942904777677254
Subject(s) - pharmacopoeia , business , quality (philosophy) , counterfeit , european union , european market , traditional medicine , political science , medicine , law , international trade , alternative medicine , philosophy , epistemology , pathology
The European Pharmacopoeia, founded in 1964, ensures the quality and safety of medicines by elaborating compulsory standards, by describing quality control methods, and by making it possible to detect counterfeit medicines. European Pharmacopoeia standards apply to all medicines regardless of their origin, their method of production or their type. The official standards published by the European Pharmacopoeia provide a legal and scientific basis for quality control during the development, production, and marketing of medicines. The establishment of the European Pharmacopoeia in Strasbourg represents an important strategic asset to the BioValley showing the trinational region as an importance life sciences cluster.